Neuropsychobiology of Fear-induced Bradycardia in Humans: Progress and Pitfalls
Overview
Affiliations
In the last century, the paradigm of fear conditioning has greatly evolved in a variety of scientific fields. The techniques, protocols, and analysis methods now most used have undergone a progressive development, theoretical and technological, improving the quality of scientific productions. Fear-induced bradycardia is among these techniques and represents the temporary deceleration of heart beats in response to negative outcomes. However, it has often been used as a secondary measure to assess defensive responding to threat, along other more popular techniques. In this review, we aim at paving the road for its employment as an additional tool in fear conditioning experiments in humans. After an overview of the studies carried out throughout the last century, we describe more recent evidence up to the most contemporary research insights. Lastly, we provide some guidelines concerning the best practices to adopt in human fear conditioning studies which aim to investigate fear-induced bradycardia.
Besson C, Baggish A, Monteventi P, Schmitt L, Stucky F, Gremeaux V Sci Rep. 2025; 15(1):5611.
PMID: 39955401 PMC: 11829968. DOI: 10.1038/s41598-025-89892-3.
AdipoRon's Impact on Alzheimer's Disease-A Systematic Review and Meta-Analysis.
Barbalho S, Fornari Laurindo L, de Oliveira Zanuso B, da Silva R, Gallerani Caglioni L, Nunes Junqueira de Moraes V Int J Mol Sci. 2025; 26(2).
PMID: 39859201 PMC: 11765103. DOI: 10.3390/ijms26020484.
Tanaka M, Szabo A, Vecsei L Int J Mol Sci. 2024; 25(23).
PMID: 39684480 PMC: 11640972. DOI: 10.3390/ijms252312767.
Ahmadi N, Ozgur S, Kiziltan E Brain Behav. 2024; 14(10):e70089.
PMID: 39378296 PMC: 11460642. DOI: 10.1002/brb3.70089.
The Involvement of Antioxidants in Cognitive Decline and Neurodegeneration: .
Nazzi C, Avenanti A, Battaglia S Antioxidants (Basel). 2024; 13(6).
PMID: 38929140 PMC: 11200558. DOI: 10.3390/antiox13060701.